8 Clarke Drive
Suite 3
Cranbury, NJ 08512
United States
609 642 6670
https://www.pmvpharma.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 54
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. David H. Mack Ph.D. | Co-Founder, CEO, Pres & Director | 889.2k | 2.17M | 1962 |
Dr. Arnold J. Levine Ph.D. | Co-Founder, Independent Director & Member of Scientific Advisory Board | 140k | N/A | 1940 |
Mr. Winston Kung M.B.A. | COO & CFO | 673.12k | 676.34k | 1976 |
Dr. Deepika Jalota Pharm.D. | Chief Regulatory & Quality Assurance Officer | 579.96k | 87.59k | 1977 |
Dr. Leila Alland M.D. | Chief Medical Officer | 685.23k | 708.15k | 1962 |
Dr. Thomas E. Shenk Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | N/A | 1947 |
Mr. Robert Ticktin | Gen. Counsel & Company Sec. | N/A | N/A | 1962 |
Mr. Tim Smith | Sr. VP & Head of Corp. Devel. | N/A | N/A | N/A |
Dr. Binh Vu Ph.D. | Sr. VP of Drug Discovery & CMC | N/A | N/A | N/A |
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
PMV Pharmaceuticals, Inc.’s ISS governance QualityScore as of 1 February 2023 is 7. The pillar scores are Audit: 6; Board: 6; Shareholder rights: 8; Compensation: 8.